Trial
NCT00523328
BG9924 in Combination With Methotrexate Extension of Study 104RA203 (NCT 00458861)
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Biogen
Collaborators
—
Condition
Rheumatoid Arthritis
Intervention
BG9924
Why stopped
Analysis of data from 104RA203 failed to meet primary endpoint.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-01-21